文章摘要
朱 珊,黄亚楷,张伟民,董 丹,闫俊强.APP/PS1年轻小鼠的早期学习记忆缺陷及血清注射治疗效果分析[J].,2019,19(5):811-815
APP/PS1年轻小鼠的早期学习记忆缺陷及血清注射治疗效果分析
Serum Injection Rescues Learning and Memory Deficits in APP/PS1 Young Mice
投稿时间:2018-08-23  修订日期:2018-09-18
DOI:10.13241/j.cnki.pmb.2019.05.003
中文关键词: 阿尔兹海默症  APP/PS1  认知能力  学习记忆  血清
英文关键词: Alzheimer's Disease  APP/PS1  Recognition  Learning and memory  Serum
基金项目:国家自然科学基金项目(U1304809)
作者单位E-mail
朱 珊 河南科技大学第一附属医院药学部 河南 洛阳 471000 zhushan1964@163.com 
黄亚楷 复旦大学附属肿瘤医院胃外科 上海 200032  
张伟民 河南科技大学第一附属医院药学部 河南 洛阳 471000  
董 丹 河南科技大学第一附属医院药学部 河南 洛阳 471000  
闫俊强 河南科技大学第一附属医院药学部 河南 洛阳 471000  
摘要点击次数: 777
全文下载次数: 713
中文摘要:
      摘要 目的:明确经典阿尔兹海默症(Alzheimer's Disease,AD)小鼠模型APP/PS1的年轻小鼠是否存在学习记忆障碍,并探讨尾静脉注射同龄小鼠的血清是否可以改善年老AD小鼠的认知能力。方法:根据转基因小鼠的基因型,将同龄小鼠分为wildtype(WT)和APP/PS1两组,首先用物体辨别实验(Novel object recognition,NOR)检测2个月龄小鼠的认知能力(90min retention: WT n=6, APP/PS1 n=8; 24hours retention: WT n=7, APP/PS1=8),同时用Morris水迷宫实验(Morris water maze,MWM)检测2个月龄小鼠的空间学习记忆能力(WT n=6, APP/PS1 n=5);采用内眦取血法从8月龄小鼠中获取全血,高速离心获得血清。将8月龄APP/PS1小鼠分为两组:对照组注射PBS(n=7),实验组注射血清(n=6),每周注射两次,100 μL/只/次,连续注射3周。注射结束后,用NOR法检测对照组和实验组小鼠的认知能力。结果:NOR实验结果显示APP/PS1小鼠的辨别指数(Discrimination index(%))显著低于WT小鼠(P<0.05);MWM实验结果显示APP/PS1小鼠到达平台的时间明显长于WT小鼠,同时在测试阶段中,APP/PS1小鼠在目的象限的探索时间及穿越次数显著低于WT小鼠(P<0.05);治疗实验中,与对照组APP/PS1小鼠的辨别指数相比较,实验组APP/PS1小鼠在注射同龄小鼠的血清后,其物体辨别指数显著升高(P<0.05),小鼠脑中的Aβ沉淀明显减少。结论:APP/PS1小鼠在2个月左右就会表现出明显的学习记忆障碍;注射正常同龄鼠的血清可以明显改善APP/PS1小鼠的学习记忆能力同时阻碍Aβ沉淀的形成。
英文摘要:
      ABSTRACT Objective: To investigate the learning and memory ability in young Alzheimer's disease (AD) APP/PS1 mouse model, and identify whether serum injection can rescue these defects. Methods: According to the genotype, the same age male mice were divided into two groups, the wildtype (WT) and APP/PS1 groups. Firstly, we performed novel object recognition (NOR) to evaluate the recogni- tion ability of two-months old male mice (90 min retention: WT n=6, APP/PS1 n=8; 24hours retention: WT n=7, APP/PS1=8), and carried out Morris water maze (MWM) to test the spatial learning and memory in two-months old mice (WT n=6, APP/PS1 n=5); Blood was col- lected from the inner canthus of 8-months old mice, and the serum was obtained by super-centrifugation. 8-months old APP/PS1 mice were divided into two groups, the control group which was injected by PBS buffer (APP/PS1 n=7), and the experimental group was in- jected with serum (APP/PS1 n=6), injection was performed twice a week, 100 μL/mice/time, for 3 weeks. After injection, NOR was per- formed to evaluate the therapeutic effect. Results: Compared with the WT mice, the discrimination index of APP/PS1 mice is significantly decreased in NOR (P<0.05). The latency of APP/PS1 mice is obviously longer than that of WT mice (P<0.05). Moreover, compared with those of WT mice, the time spent and crossing number of APP/PS1 in target quadrant are significantly reduced during the testing stage (P<0.05). About the rescue experiment, we find that the group which injected with serum obtained higher discrimination index and less Aβ plaque than those in PBS injected group(P<0.05). Conclusion: Obvious learning and memory deficits occurred in APP/PS1 young mice at about 2-months old, and the same-age serum injection could rescue recognition defects and reduce Aβ formation in APP/PS1 mice.
查看全文   查看/发表评论  下载PDF阅读器
关闭